In a report released yesterday, Benjamin Theurer from Barclays maintained a Hold rating on Ingredion (INGR – Research Report), with a price target of $115.00. The company’s shares closed yesterday at $115.20.
According to TipRanks, Theurer is a 4-star analyst with an average return of 5.6% and a 55.61% success rate. Theurer covers the Consumer Defensive sector, focusing on stocks such as Ingredion, Tyson Foods, and Coca Cola Femsa SAB De CV.
Currently, the analyst consensus on Ingredion is a Moderate Buy with an average price target of $126.00, representing a 9.38% upside. In a report released on February 7, BMO Capital also maintained a Hold rating on the stock with a $117.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
INGR market cap is currently $7.55B and has a P/E ratio of 12.07.
Based on the recent corporate insider activity of 110 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of INGR in relation to earlier this year. Earlier this month, Larry Fernandes, the SVP, Chief Comm & Sust Officer of INGR sold 2,369.00 shares for a total of $272,600.83.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Ingredion (INGR) Company Description:
Ingredion, Inc. manufactures and sells sweetener, starches, nutrition ingredients, and biomaterial solutions derived from the wet milling and processing of corn and other starch based materials. Its activities include turning corn, tapioca, potatoes and other vegetables and fruits into value added ingredients and biomaterials for the food, beverage, paper and corrugating, brewing, and other industries. The company was founded in 1906 and is headquartered in Westchester, IL.
Read More on INGR:
- Snowflake downgraded, Coinbase upgraded: Wall Street’s top analyst calls
- Ingredion upgraded to Buy from Neutral at Goldman Sachs
- Ingredion to Present at CAGNY 2024 Conference
- Ingredion price target raised to $125 from $120 at Oppenheimer
- Ingredion sees Q1 revenue down mid-single-digits, consensus $2.09B
